RXRX Sale Disclosure
Borgeson Blake · SEC Form 4 · Filed Oct 7, 2026
Sale
Calculated transaction value
$242K
Borgeson Blake Director
RXRX
Transaction date
Oct 6, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 1 day later
RXRX daily price context
Close on/before transaction
$4.63
Oct 6, 2026
First close after public filing
$3.95
Oct 8, 2026
Return after filing · so far
+10.38%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 50,000 shares @ $4.84
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001601830-26-000120
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$242K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Sale | Oct 6, 2026 | $242K |